ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,495.20
0.56%
S&P ASX All Technology
4,017.00
1.28%
Brent Oil
73.76
2.60%
US Dollar vs AUD
1.5425
-0.13%
Bitcoin
95,175.84
-0.72%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. E-therapeutics Plc (ETX) Share Price

E-therapeutics Plc

E-therapeutics Plc (ETX)

Eaton Vance Municipal Income 2028 Term Trust
Maurel Et Prom
9.00
0.00
(0.00%)
Closed 04 December 3:30AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
9.00
Bid
9.00
Offer
9.50
Volume
0.00
0.00 Day's Range 0.00
8.00 52 Week Range 18.50
Market Cap
52.546M
Previous Close
9.00
Open
-
Last Trade
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
0.00
Shares Outstanding
583,844,162
Dividend Yield
-
PE Ratio
-4.71
Earnings Per Share (EPS)
-0.02
Revenue
318k
Net Profit
-11.17M

About E-therapeutics Plc

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Website
www.etherapeutics.co.uk
Headquarters
London, Gbr
Founded
-
E-therapeutics Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker ETX. The last closing price for E-therapeutics was 9p. Over the last year, E-therapeutics shares have traded in a share price range of 8.00p to 18.50p.

E-therapeutics currently has 583,844,162 shares in issue. The market capitalisation of E-therapeutics is £52.55 million. E-therapeutics has a price to earnings ratio (PE ratio) of -4.71.

Ask ADVFN Intelligence (AI)

ETX Latest News

More News

e-therapeutics Announces Business Updates and Interim Results

e-therapeutics Announces Business Updates and Interim Results LONDON, Oct. 31, 2024 (GLOBE NEWSWIRE) -- e-therapeutics plc, a company integrating computational power and biological data to...

01 November 2024
UK Regulatory

AIM Cancellation - e-Therapeutics Plc

AIM 09 May 2024   NOTICE   09/05/2024 - 07:00   NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM   At the request of the company the following securities have been cancelled from trading...

09 May 2024
RNS Regulatory News

e-Therapeutics plc Last Day of Dealings on AIM

e-Therapeutics plc 08 May 2024       e-therapeutics plc   ("e-therapeutics" or "ETX" or the "Company")    Last Day of Dealings on AIM     London, UK, 8 May 2024 - e-therapeutics plc (AIM:...

08 May 2024
RNS Regulatory News

FTSE Russell e-therapeutics

FTSE Russell 03 May 2024       E-therapeutics (UK): Constituent Deletion Changes in FTSE UK Index Series 03 May 2024 Subject to the expected cancellation of trading on AIM for E-therapeutics...

04 May 2024
RNS Regulatory News

e-Therapeutics plc Result of General Meeting

e-Therapeutics plc 29 April 2024         e-therapeutics plc   ("e-therapeutics" or "ETX" or the "Company")    Result of General Meeting  Matched Bargain Settlement Facility     London, UK, 29...

29 April 2024
RNS Regulatory News

e-Therapeutics says company faces lack of interest as UK listing

e-Therapeutics PLC on Wednesday announced its intention to cancel its admission to AIM and instead explore the option ...

10 April 2024
Alliance News

e-Therapeutics plc Proposed Fundraise of £28.9m and Cancellation

e-Therapeutics plc 10 April 2024       This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 as it forms part of UK domestic law by virtue...

10 April 2024
RNS Regulatory News

e-Therapeutics plc Total Voting Rights

e-Therapeutics plc 31 January 2024     e-therapeutics plc ("e-therapeutics" or the "Company")   Total Voting Rights     London, UK, 31 January 2024 - e-therapeutics plc (AIM: ETX), a company...

01 February 2024
RNS Regulatory News

e-Therapeutics plc Exercise of Options and Issue of Equity

e-Therapeutics plc 24 January 2024 e-therapeutics plc ("e-therapeutics" or the "Company") Exercise of Options and Issue of Equity London, UK, 24 January 2024 - e-therapeutics...

24 January 2024
UK Regulatory

IN BRIEF: e-Therapeutics shares rise on strong financial year

C - Oxford, England-based computer-based drug discovery company - Says 2023 was "a year of significant execution and ...

16 January 2024
Alliance News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10099900DE
40099900DE
120099900DE
260099900DE
5200918.5827774711.34481341DE
156-35-79.54545454554448.4824066618.45950623DE
2605.75176.9230769233.2548.42.9559220017.49654362DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SCGLSealand Capital Galaxy Limited
0.54p
(80.00%)
30.47M
OBDOxford Biodynamics Plc
2.11p
(55.15%)
8.03M
MIRIMirriad Advertising Plc
0.18p
(33.33%)
23.04M
CLCOCloudcoco Group Plc
0.26p
(30.00%)
3.42M
IESInvinity Energy Systems Plc
15.00p
(27.66%)
4.57M
ZNTZentra Group Plc
3.50p
(-36.36%)
221.85k
UOGUnited Oil & Gas Plc
0.125p
(-34.21%)
123.45M
SYSSysgroup Plc
21.50p
(-24.56%)
788.98k
ADAAdams Plc
3.50p
(-22.22%)
25k
DSMDowning Strategic Micro-cap Investment Trust Plc
3.70p
(-21.28%)
22.32k
ORCPOracle Power Plc
0.0525p
(-7.89%)
3.63B
NTVONativo Resources Plc
0.0023p
(-8.00%)
1.51B
SYMESupply@me Capital Plc
0.0031p
(-10.14%)
1.11B
KEFIKefi Gold And Copper Plc
0.524p
(-19.63%)
561.97M
ENETEthernity Networks Ltd
0.1425p
(18.75%)
547.92M

Discussion

View Full Feed
NickyCapone NickyCapone 4 minutes ago
https://share.icloud.com/photos/0bbZF_t9tlGxTHW381mAjW_Ow
AMC
PonkenPlonken PonkenPlonken 5 minutes ago
Thank you for sharing!
They seem to believe this makes it to market in CRC is my read.
NVCR
coolhandluke88 coolhandluke88 5 minutes ago
If you voted for Kamala enough said. You better just get out of the markets and not prosper this next 4 years. Hilter are you seriously peddling that bs. Such week minds.
GRST
ANTI-BAGHOLDER ANTI-BAGHOLDER 5 minutes ago
Must be the peeps waiting on the 20 year audit, or the best chart in the OTC, or HUGE news coming?

Has to be one of those, no?
SPZI
Serpico2005 Serpico2005 5 minutes ago
I'm asking the same questions, it seems people are losing patience with this. 
SPZI
flipper44 flipper44 5 minutes ago
Market Makers are writing their own damages epitaph.
NWBO
Jetmek_03052 Jetmek_03052 6 minutes ago
It would be just like Linda to file the application for the QB level, while knowing that the company's governance situation made them ineligible for it.

That way, she could put out a nice fluffy update, claiming that DBMM was "working" with the OTCM to uplist to the QB level. She wou
DBMM OTCM
Gmenfan Gmenfan 6 minutes ago
The Governors and Mayors that want to hinder ICE may want to take a different stance!
Rodney5 Rodney5 6 minutes ago
FFFacts, as you said be concise and clear. There is not an unlimited amount of funding available from the Treasury.

The difference in what the Treasury had authority to do and what actually happened during conservatorship as it relates to Treasury's actions, simplified.
FNMA
pzottkpz pzottkpz 6 minutes ago
⏲️

💲TLRY
TLRY
AJH92 AJH92 6 minutes ago
Update - December 3: "Check out the article from Fox News Digital. They reached out to our CEO, Tony Torgerud a couple weeks ago with some questions.

https://foxnews.com/food-drink/beer-taste-great-there-health-benefits-associated

#doinitright #themissingelemwntyounee
APRU
delerious1 delerious1 6 minutes ago
CHARBONE HYDROGEN CORPORATION ("CH")
BULLETIN TYPE: Shares for Debt
BULLETIN DATE: October 2, 2024
TSX Venture Tier 2 Company

TSX Venture Exchange has accepted for filing the Company's proposal to issue 1,800,000 common shares at a deemed price of $0.10 per comm
Werbe Werbe 6 minutes ago
Mexedia owns Phonetime and Matchcom, theyre obligors on the 44 million loan. They are paying a million a month to pay this off. If they default, credit facility takes all Mexedia assets.

A default under our $45 million credit facility agreement could result in our lender foreclosing
RDAR
delerious1 delerious1 6 minutes ago
CHARBONE HYDROGEN CORPORATION ("CH")
BULLETIN TYPE: Shares for Debt
BULLETIN DATE: October 2, 2024
TSX Venture Tier 2 Company

TSX Venture Exchange has accepted for filing the Company's proposal to issue 1,800,000 common shares at a deemed price of $0.10 per comm
CHHYF
solidgold solidgold 7 minutes ago
MANIPULATION.
NBRI
Gmenfan Gmenfan 7 minutes ago
I wonder what the Governors and Mayors that are going to hinder ICE think about the ruling?
georgie18 georgie18 8 minutes ago
Thanks Pink...🥳
oldstocks oldstocks 8 minutes ago
Because i told everyone on all the boards to boycott the stock until the company posts more often and more details.

That means, no selling, no buying

That also means for the company not to issue any new shares because we are not buying until they inform us on LinkedIn
AFFU
FooBarAndGrill FooBarAndGrill 8 minutes ago
Loaded at $38!!! Oh really?
https://investorshub.advfn.com/uimage/uploads/2024/12/3/ilnlxScreenshot_2024-12-03_11.17.17_AM.png
SMCI
jimmybob jimmybob 8 minutes ago
PTON back over 10
PTON
coolhandluke88 coolhandluke88 9 minutes ago
Keep drinking the Kool aid you idiot. Jim Jones needed idiots like you. Biden wasn't going to pardon Hunter too. lol
GRST

Your Recent History

LSE
ETX
E-therapeutics
FX
USDBRL
US Dollar vs BRL
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved